Browse by obesity medication
Browse by medication.
We track 27 obesity medications across multiple drug classes. Pick a drug to see plan-by-plan answers — including which plans cover it, which require prior authorization, and which exclude it.
Paying without insurance
Cheapest cash-pay options today
- Adipex-P / Lomaira
$15 (Cost Plus) / $16.85 (GoodRx)
- Foundayo
$149 (LillyDirect)
- Wegovy (oral)
$149 (NovoCare) / $149 (TrumpRx)
GIP/GLP-1 RA
2 medications
GLP-1 RA
10 medications
Trulicity
dulaglutide
GLP-1 RANo plan decisions recorded yet.
Bydureon Bcise
exenatide
GLP-1 RANo plan decisions recorded yet.
Saxenda
liraglutide
GLP-1 RACovered by 17 of 32 tracked plans
Victoza
liraglutide
GLP-1 RANo plan decisions recorded yet.
Foundayo
orforglipron
GLP-1 RACovered by 0 of 13 tracked plans
Ozempic
semaglutide
GLP-1 RACovered by 26 of 26 tracked plans
Wegovy
semaglutide
GLP-1 RACovered by 21 of 40 tracked plans
Wegovy HD
semaglutide (7.2 mg injection)
GLP-1 RACovered by 5 of 13 tracked plans
Rybelsus
semaglutide (oral)
GLP-1 RANo plan decisions recorded yet.
Wegovy (oral)
semaglutide (oral, 1.5/4/9/25 mg tablets)
GLP-1 RACovered by 6 of 15 tracked plans
Combination AOM
2 medications
Anti-obesity medications
1 medication
Biguanide
1 medication
DPP-4 inhibitor
3 medications
Lipase inhibitor
2 medications
Other antidiabetic
1 medication
SGLT2 inhibitor
1 medication
Sulfonylurea
2 medications
Sympathomimetic (AOM)
1 medication
Unclassified
1 medication
Browse by insurer
Start with your insurer and drill into the plans we track.
Compare cash prices
Side-by-side pricing across NovoCare, LillyDirect, GoodRx, and Cost Plus.
Learn how these drugs work
Plain-language guides to GLP-1 agonists, combination AOMs, and more.